Evaluating an Adjunct Therapy for Cushing’s Disease
Researchers will study if the addition of the drug cyproheptadine improves clinical signs and blood parameters in horses receiving the standard-of-care treatment for pituitary pars intermedia dysfunction (Cushing’s Disease).